M
Madison E. Weirick
Researcher at University of Pennsylvania
Publications - 39
Citations - 5113
Madison E. Weirick is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Antibody & Immune system. The author has an hindex of 18, co-authored 34 publications receiving 2002 citations.
Papers
More filters
Posted ContentDOI
SARS-CoV-2 Seroprevalence Among Parturient Women
Dustin D. Flannery,Dustin D. Flannery,Sigrid Gouma,Miren B. Dhudasia,Sagori Mukhopadhyay,Sagori Mukhopadhyay,Madeline R. Pfeifer,Emily C. Woodford,Jeffrey S. Gerber,Jeffrey S. Gerber,Claudia P. Arevalo,Marcus J. Bolton,Madison E. Weirick,Eileen C. Goodwin,Elizabeth M. Anderson,Allison R. Greenplate,Justin Kim,Nicholas Han,Ajinkya Pattekar,Jeanette Dougherty,Olivia Kuthuru,Divij Mathew,Amy E. Baxter,Laura A. Vella,Laura A. Vella,JoEllen Weaver,Anurag Verma,Rita Leite,Jeffrey S. Morris,Daniel J. Rader,Michal A. Elovitz,E. John Wherry,Karen M. Puopolo,Karen M. Puopolo,Scott E. Hensley +34 more
TL;DR: Serological tests are critically important to determine exposure and immunity to SARS-CoV-2 within both individuals and populations and race/ethnicity differences in seroprevalence rates are found.
Posted ContentDOI
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
Sigrid Gouma,Kangchon Kim,Madison E. Weirick,Megan E. Gumina,Angela Branche,David J. Topham,Emily T. Martin,Arnold S. Monto,Sarah Cobey,Scott E. Hensley +9 more
TL;DR: It is found that most humans who were first infected in childhood with H3N2 viral strains from the 1960s and 1970s possess non-neutralizing antibodies against contemporary 3c2.A H3n2 viruses.
Posted ContentDOI
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
Elizabeth M. Anderson,Caroline Diorio,Eileen C. Goodwin,Kevin O McNerney,Madison E. Weirick,Sigrid Gouma,Marcus J. Bolton,Claudia P. Arevalo,Julie Chase,Philip Hicks,Tomaz B. Manzoni,Amy E. Baxter,Kurt P Andrea,Chakkapong Burudpakdee,Jessica H. Lee,Laura A. Vella,Sarah E. Henrickson,Rebecca M. Harris,E. John Wherry,Paul Bates,Hamid Bassiri,Edward M. Behrens,David T. Teachey,Scott E. Hensley +23 more
TL;DR: It is shown that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
Journal ArticleDOI
Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration.
Sigrid Gouma,Madison E. Weirick,Marcus J. Bolton,Claudia P. Arevalo,Eileen C. Goodwin,Elizabeth M. Anderson,Christopher M McAllister,Shannon R. Christensen,Debora Dunbar,Danielle Fiore,Amanda Brock,JoEllen Weaver,John S. Millar,Stephanie DerOhannessian,Ian Frank,Daniel J. Rader,E. John Wherry,Scott E. Hensley +17 more
TL;DR: In this article, the authors found that the duration of symptoms following SARS-CoV-2 infections was significantly reduced in individuals with higher common betacoronavirus (sCoV) antibody titers.
Journal ArticleDOI
Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
TL;DR: It is found that the egg-adapted H3N2 vaccine strain elicits antibodies that have reduced reactivity to a wild-type 3c3.A strain and very limited reactivityTo 3c2.A1b strain, which is currently circulating in ferrets and humans.